参考文献/References:
[1] de Rooij NK, Linn FH, van der Plas JA, et al. Incidence of
subarachnoid haemorrhage: a systematic review with em-
phasis on region, age, gender and time trends [J]. J Neurol
Neurosurg Psychiatry, 2007, 78(12): 1365-1372.
[2] van Gijn J, Rinkel GJ. Subarachnoid haemorrhage: diagno-
sis, causes and management [J]. Brain, 2001, 124(Pt 2):
249-278.
[3] 胡 焱，李 健，李小龙，等. 颅内动脉瘤栓塞术后并发脑
缺血11例报告[J]. 中国临床神经外科杂志，2014，19：
766.
[4] 张 华，王军民，杨 海，等. 颅内动脉瘤栓塞治疗并发大
面积脑梗死的原因分析及防治方法[J]. 中国临床神经外
科杂志，2013，18：276-278.
[5] 董宇峰，麻晓融，高 麟，等. 脑脊液置换联合尼莫地平治
疗创伤性蛛网膜下腔出血的体会[J]. 中国临床神经外科
杂志，2011，16：491-492.
[6] 李洛阳，秦尚振，胡军民，等. 尼莫地平对创伤性蛛网膜下
腔出血的临床疗效[J]. 中国临床神经外科杂志，2014，
19：7-10.
[7] Liu GJ, Luo J, Zhang LP, et al. Meta-analysis of the effec-
tiveness and safety of prophylactic use of nimodipine in
patients with an aneurysmal subarachnoid haemorrhage [J].
CNS Neurol Disord Drug Targets, 2011, 10(7): 834-844.
[8] Pickard JD, Murray GD, Illingworth R, et al. Effect of oral
nimodipine on cerebral infarction and outcome after subara-
chnoid haemorrhage: British aneurysm nimodipine trial [J].
BMJ, 1989, 298(6674): 636-642.
[9] Desbordes JM, Ades PE, Guggiari M. Intravenous nimodi-
pine in the treatment of cerebral vasospasm following sub-
arachnoid hemorrhage caused by aneurysm rupture: a com-
parative multicenter study [J]. Agressologie, 1989, 30(7):
438-440.
[10] Kronvall E, Undren P, Romner B, et al. Nimodipine in aneu-
rysmal subarachnoid hemorrhage: a randomized study of
intravenous or peroral administration [J]. J Neurosurg, 2009,
110(1): 58-63.
[11] Connolly EJ, Rabinstein AA, Carhuapoma JR, et al. Guide-
lines for the management of aneurysmal subarachnoid
hemorrhage: a guideline for healthcare professionals from
the American Heart Association/american Stroke Associa-
tion [J]. Stroke, 2012, 43(6): 1711-1737.
[12] Haley EC Jr, Kassell NF, Torner JC. A randomized control-
led trial of high-dose intravenous nicardipine in aneurysmal
subarachnoid hemorrhage. A report of the Cooperative
Aneurysm Study [J]. J Neurosurg, 1993, 78(4): 537-547.
[13] Barth M, Capelle HH, Weidauer S, et al. Effect of nicardi-
pine prolonged-release implants on cerebral vasospasm and
clinical outcome after severe aneurysmal subarachnoid
hemorrhage: a prospective, randomized, double-blind phase
Ⅱa study [J]. Stroke, 2007, 38(2): 330-336.
[14] Shibuya M, Suzuki Y, Sugita K, et al. Effect of AT877 on
cerebral vasospasm after aneurysmal subarachnoid hemo-
rrhage: results of a prospective placebo-controlled double-
blind trial [J]. J Neurosurg, 1992, 76(4): 571-577.
[15] 马景鑑，杨树源，魏 伟，等. 盐酸法舒地尔治疗蛛网膜下
腔出血所致脑血管痉挛的临床Ⅱ期试验研究[J]. 中华神
经外科杂志，2006，22：36-40.
[16] 马景鑑，王 东，张建军，等. 法舒地尔治疗蛛网膜下腔出
血后脑血管痉挛有效性和安全性的临床评价—Ⅳ期临
床试验报告[J]. 中华神经外科杂志，2011，27：1117-1122.
[17] 谢丽华，张俊玲，侯玉立. 法舒地尔治疗SAH后脑血管痉
挛的系统评价[J]. 中国临床神经外科杂志，2011，16：
200-203.
[18] Mcgirt MJ, Garces AG, Huang J, et al. Simvastatin for the
prevention of symptomatic cerebral vasospasm following
aneurysmal subarachnoid hemorrhage: a single-institution
prospective cohort study [J]. J Neurosurg, 2009, 110(5):
968-974.
[19] Vergouwen MD, de Haan RJ, Vermeulen M, et al. Effect of
statin treatment on vasospasm, delayed cerebral ischemia,
and functional outcome in patients with aneurysmal subara-
chnoid hemorrhage: a systematic review and meta-analysis
update [J]. Stroke, 2010, 41(1): e47-e52.
[20] Macdonald RL, Kassell NF, Mayer S, et al. Clazosentan to
overcome neurological ischemia and infarction occurring
after subarachnoid hemorrhage (CONSCIOUS-1): rando-
mized, double-blind, placebo-controlled phase 2 dose-
finding trial [J]. Stroke, 2008, 39(11): 3015-3021.
[21] Macdonald RL, Higashida RT, Keller E, et al. Clazosentan,
an endothelin receptor antagonist, in patients with aneury-
smal subarachnoid haemorrhage undergoing surgical
clipping: a randomised, double-blind, placebo-controlled
phase 3 trial (CONSCIOUS-2) [J]. Lancet Neurol, 2011, 10
(7): 618-625.
[22] Shen J, Pan JW, Fan ZX, et al. Dissociation of vasospasm-
related morbidity and outcomes in patients with aneurysmal
subarachnoid hemorrhage treated with clazosentan: a
meta-analysis of randomized controlled trials [J]. J Neuro-
surg, 2013, 119(1): 180-189.
[23] Dorhout Mees SM, Algra A, Vandertop WP, et al. Magne-
sium for aneurysmal subarachnoid haemorrhage (MASH-2):
a randomised placebo-controlled trial [J]. Lancet, 2012, 380
(9836):44-49.
[24] Yarad EA, Hammond NE. Intravenous magnesium therapy
in adult patients with an aneurysmal subarachnoid haemo-
rrhage: a systematic review and metaanalysis [J]. Aust Crit
Care, 2013, 26(3): 105-117.
[25] Senbokuya N, Kinouchi H, Kanemaru K, et al. Effects of
cilostazol on cerebral vasospasm after aneurysmal subarac-
hnoid hemorrhage: a multicenter prospective, randomized,
open-label blinded end point trial [J]. J Neurosurg, 2013,
118(1): 121-130.
[26] 李春坡，郑 军. 病灶切除结合周围痫灶皮层热灼治疗
继发性癫痫（附18例报告）[J]. 中国临床神经外科杂志，
2012，17：200-202.
[27] 伍伟俊，张 珑，钱锁开，等. 一氧化氮合酶基因对兔
SAH后大脑中动脉超微结构变化的影响[J]. 中国临床神
经外科杂志，2013，18：106-108.
[28] Hwang SH, Park YS, Kwon JT, et al. Significance of C-
reactive protein and transcranial Doppler in cerebral vaso-
spasm following aneurysmal subarachnoid hemorrhage [J]. J
Korean Neurosurg Soc, 2013, 54(4): 289-295.
相似文献/References:
[1]旷仁钊 唐晓平 漆 建 苟章洋.丹红注射液对大鼠蛛网膜下腔出血后脑血管痉挛的影响[J].中国临床神经外科杂志,2015,(11):683.[doi:10.13798/j.issn.1009-153X.2015.11.014]
KUANG Ren-zhao,TANG Xiao-ping,QI Jian,et al.Effects of Danhong on cerebral vasospasm after subara- chnoid hemorrhage in rats[J].,2015,(08):683.[doi:10.13798/j.issn.1009-153X.2015.11.014]
[2]周路桥 罗富强 彭 虎 邱成元 刘 苏 蒋国辉 田 强 罗荣武.皮瓣塌陷综合征患者颅骨修补术后继发蛛网膜下腔出血1例[J].中国临床神经外科杂志,2015,(11):704.[doi:10.13798/j.issn.1009-153X.2015.11.022]
[3]曾 春 张施远 蒋永明.复合手术与常规夹闭术治疗颈内动脉后交通动脉破裂动脉瘤的疗效对比研究[J].中国临床神经外科杂志,2016,(05):257.[doi:10.13798/j.issn.1009-153X.2016.05.001]
ZENG Chun,ZHANG Shi-yuan,JIANG Yong-ming.Analysis of the effects of hybrid surgery on posterior communicating artery aneurysms: a comparison with conventional craniotomy[J].,2016,(08):257.[doi:10.13798/j.issn.1009-153X.2016.05.001]
[4]周有东 敖祥生 刘汉东 王志勇 朱耀祖 周达全.支架辅助弹簧圈和单纯弹簧圈栓塞治疗颅内动脉瘤疗效及安全性的Meta分析[J].中国临床神经外科杂志,2016,(05):274.[doi:10.13798/j.issn.1009-153X.2016.05.006]
ZHOU You-dong,AO Xiang-sheng,LIU Han-dong,et al.A mata-analysis of curative effects of stent-assisted coiling and simple coiling on intracranial aneurysms and their safety[J].,2016,(08):274.[doi:10.13798/j.issn.1009-153X.2016.05.006]
[5]赵 平 王雄伟 汪 雷 马金阳.显微手术和血管内栓塞术治疗颅内动脉瘤的疗效分析[J].中国临床神经外科杂志,2016,(05):281.[doi:10.13798/j.issn.1009-153X.2016.05.008]
ZHAO Ping,WANG Xiong-wei,WANG Lei,et al.Effect of endovascular treatment on intracranial aneurysms: a comparison with microsurgery[J].,2016,(08):281.[doi:10.13798/j.issn.1009-153X.2016.05.008]
[6]刘福德 邓剑平 张 涛 陈 虎 李 帅 王俭博 曲友直 赵振伟.椎-基底动脉夹层动脉瘤的血管内治疗（附48例分析）[J].中国临床神经外科杂志,2016,(06):353.[doi:10.13798/j.issn.1009-153X.2016.06.011]
LIU Fu-de,DENG Jian-ping,ZHANG Tao,et al.Endovascular treatment of vertebrobasilar artery dissecting aneurysms (report of 48 cases)[J].,2016,(08):353.[doi:10.13798/j.issn.1009-153X.2016.06.011]
[7]余龙洋 李亚楠 周 宇 戴冬伟 曹依群 岳志健.垂体腺瘤经蝶术后并发蛛网膜下腔出血的临床分析
（附6例报道）[J].中国临床神经外科杂志,2016,(06):372.[doi:10.13798/j.issn.1009-153X.2016.06.018]
[8]吴有志 罗良生 张 健 陈 骅 吴 鸣 刘 振 史 岩.前循环破裂动脉瘤伴脑内血肿的
早期显微手术治疗[J].中国临床神经外科杂志,2016,(06):376.[doi:10.13798/j.issn.1009-153X.2016.06.020]
[9]潘 力 刘 鹏 秦 杰 杨 柳 安学峰 吴 虓 杨 铭 徐国政 马廉亭.Y型支架辅助技术在颅内动脉分叉部宽颈动脉瘤治疗中的应用[J].中国临床神经外科杂志,2016,(07):394.[doi:10.13798/j.issn.1009-153X.2016.07.002]
PAN Li,LIU Peng,QIN Jie,et al.Application of Y -configuration stent technique to treatment of intracranial wide-neck bifurcation aneurysms[J].,2016,(08):394.[doi:10.13798/j.issn.1009-153X.2016.07.002]
[10]张 莹 荆林凯 张倩倩 刘 健 张义森 王 坤 穆士卿 杨新健.颈内动脉后交通动脉小动脉瘤破裂危险因素分析[J].中国临床神经外科杂志,2016,(03):138.[doi:10.13798/j.issn.1009-153X.2016.03.002]
ZHANG Ying,JING Lin-kai,ZHANG Qian-qian,et al.Analysis of risk factors related to rupture of small (diameter ≤5 mm) posterior communicating artery aneurysms[J].,2016,(08):138.[doi:10.13798/j.issn.1009-153X.2016.03.002]
[11]李朝晖 王玉贵 张孟超 综述 赵兴利 审校.CT灌注成像在动脉瘤性蛛网膜下腔出血中的
临床应用进展[J].中国临床神经外科杂志,2016,(05):313.[doi:10.13798/j.issn.1009-153X.2016.05.021]
[12]周 量 刘 丛 张昌伟.早期栓塞术治疗动脉瘤性蛛网膜下腔出血的疗效[J].中国临床神经外科杂志,2016,(07):410.[doi:10.13798/j.issn.1009-153X.2016.07.007]
ZHOU Liang,LIU Cong,ZHANG Chang-wei..Curative effect of early endovascular embolization on patients with ruptured intracranial aneurysms[J].,2016,(08):410.[doi:10.13798/j.issn.1009-153X.2016.07.007]
[13]朱作磊 综述 罗良生 审校.动脉瘤性蛛网膜下腔出血的预后相关因素研究进展[J].中国临床神经外科杂志,2016,(03):183.[doi:10.13798/j.issn.1009-153X.2016.03.020]
[14]祝 源 李 俊 陈 刚 向伟楚 李国栋 赵曰圆 李欢欢 汤 伟 金二亮 马廉亭.两次DSA阴性的颅内破裂动脉瘤1例报道并文献复习[J].中国临床神经外科杂志,2015,(09):538.[doi:10.13798/j.issn.1009-153X.2015.09.009]
ZHU Yuan,LI Jun,CHEN Gang,et al.Both negative DSA findings in 1 patient with ruptured intracranial aneurysm (case report and review of literature)[J].,2015,(08):538.[doi:10.13798/j.issn.1009-153X.2015.09.009]
[15]赵乐,综述,曹毅,等.尼莫地平在aSAH治疗中的研究进展[J].中国临床神经外科杂志,2017,(02):115.[doi:10.13798/j.issn.1009-153X.2017.02.020]
[16]焦 猛 综述 窦长武 审校.动脉瘤性蛛网膜下腔出血后脑积水的危险因素[J].中国临床神经外科杂志,2017,(04):273.[doi:10.13798/j.issn.1009-153X.2017.04.027]
[17]闵 杰 王 仙 张 双 杨 磊 陈世洁.多囊肾合并动脉瘤性蛛网膜下腔出血1例[J].中国临床神经外科杂志,2017,(08):548.[doi:10.13798/j.issn.1009-153X.2017.08.008]
[18]杨洪宽 陈 豪 陈如东 厉 华 于加省 雷 霆.大脑前动脉A1段动脉瘤的临床特点及治疗（附8例分析）[J].中国临床神经外科杂志,2017,(09):613.[doi:10.13798/j.issn.1009-153X.2017.09.002]
YANG Hong-kuan,CHEN Hao,CHEN Ru-dong,et al.Clinical characteristics and treatment of aneurysms arising from anterior cerebral artery A1 segment[J].,2017,(08):613.[doi:10.13798/j.issn.1009-153X.2017.09.002]
[19]陈华轩 张 渊 王 林 宋旭东 刘 毅 范润金.缺血修饰白蛋白对动脉瘤性蛛网膜下腔出血后脑血管痉挛的评估价值[J].中国临床神经外科杂志,2019,(01):26.[doi:10.13798/j.issn.1009-153X.2019.01.007]
CHEN Hua-xuan,ZHANG Yuan,WANG Lin,et al.Value of ischemia-modified albumin to assesment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage[J].,2019,(08):26.[doi:10.13798/j.issn.1009-153X.2019.01.007]
[20]谭占国 黄圣明.蛛网膜下腔出血后迟发脑血管痉挛诊治新进展[J].中国临床神经外科杂志,2019,(08):505.[doi:10.13798/j.issn.1009-153X.2019.08.020]